NIH-funded research R21 grant

Axon-guidance genes and ALS/FTD: how neuron paths go wrong

Official title: Axon guidance deregulation in ALS and frontotemporal dementia

Funded at University of Wisconsin-Madison · NIH-11458497 · Data updated 2026-11-12

A short-term NIH grant will explore how axon guidance genes contribute to ALS and frontotemporal dementia in people and neuronal cells.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startAugust 1, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$427,625
NIH project number1R21NS147268-01A1
Project IDNIH-11458497 on NIH RePORTER

Who could benefit from this research

Could help

People with ALS or FTD or those at risk may eventually benefit from therapies targeting UBQLN2-related pathways.

Less likely to help

This specific basic science study does not directly enroll patients or provide immediate treatment.

What this research studies

This project uses a “fly to human” approach to find how UBQLN2 mutations drive neurodegeneration in ALS and FTD, starting with fruit fly models and then testing findings in patient-derived motor neurons. The researchers will perform genetic screens to identify axon guidance pathways that modify UBQLN2 toxicity, aiming to uncover mechanisms that lead to neuron damage. By linking basic gene pathways to human neuron behavior, the study could point to new targets for therapies in ALS/FTD.

Why it matters

Potential benefit: If successful, the work could reveal new targets to slow or prevent neuron damage in ALS and FTD.

How similar studies have gone: Previous work shows UBQLN2 mutations promote protein aggregation and neurodegeneration in model systems, with multiple pathways still being explored.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Tibbetts, Randal Scot — University of Wisconsin-Madison
  • Study coordinator: Tibbetts, Randal Scot

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.